
Research ArticleCombination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
Keywords: هپاتیت ب; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; FACS; fluorescent-activated cell sorting; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; HDAC; histone deacetylase; HDACi; histone deacetylase inhibitor; HSP90;